| Revenues | | 167.01 | 159.91 | 156.37 |
| | 15.61 | 15.57 | - |
| Research and Development | | 15.61 | 15.57 | - |
| Costs And Expenses | | 125.07 | 130.90 | 103.65 |
| Operating Income/Loss | | 41.94 | 29.01 | 52.72 |
| Income/Loss From Equity Method Investments | | -0.42 | -0.77 | - |
| Income/Loss From Continuing Operations Before Tax | | 38.10 | 21.35 | 58.36 |
| Income Tax Expense/Benefit | | -6.95 | 6.27 | -31.46 |
| | 45.05 | 15.08 | 89.82 |
| Attributable To Parent | | 44.95 | 15.16 | 89.58 |
| Available To Common Stockholders, Basic | | 44.95 | 23.03 | 43.78 |
| Attributable To Noncontrolling Interest | | 0.10 | -0.08 | 0.25 |
| Basic Average Shares | | 217.28 | - | 103.57 |
| Diluted Average Shares | | 248.83 | - | 129.92 |
| Basic Earnings Per Share | | 0.21 | - | 0.42 |
| Diluted Earnings Per Share | | 0.18 | - | 0.34 |
| Undistributed Earnings/Loss Allocated To Participating Securities, Basic | - | - | -7.87 | 45.79 |